Mednet Logo
CommunityPsychiatry

How do you counsel patients on the risks and benefits of antidepressant use during pregnancy?

How do you approach shared decision-making when patients express hesitancy about medication exposure in utero? What is your approach when a patient is stable on a less-studied or higher-risk agent such as paroxetine? Do you use any patient-facing educational resources or decision aids to guide these discussions?
4 Answers
Mednet Member
Mednet MemberInvited Expert
Psychiatry · Oregon Health Sciences University
Answered on

I always frame the decision as being between the risks and benefits of the medication vs. the underlying condition. We are always aiming for the "minimum effective dose" but "effective" is just as important as "minimum." Medications are, of course, not the only way to treat psychiatric illness and a...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Psychiatry · RK Psychiatry Associates, LLC
Answered on

I tell patients that untreated depression carries clear risks to both mother and fetus, and relapse rates are high if a stable regimen is stopped. For someone doing well, pregnancy is usually not the time to change medication unless we planned it well before conception. I start these conversations e...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Psychiatry · George Washington University School of Medicine
Answered on

I emphasize that although pregnant women are excluded from research studies, we have data on literally tens of thousands of women who have taken medication during pregnancy, based on international registries. All except Depakote/valproic acid and, to a lesser extent, carbamazepine have very reassuri...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Psychiatry · Fairfax County Government
Answered on

Join for free or sign in to see the full answer